Search research articles
Contact Us
Filters
Showing results (1-10 of 85) with videos related to
Page
of 9
Sort By:
Clinical Advances in Hematology & Oncology : H&O
|
May 27, 2006
Myeloma and bone disease: "the dangerous tango"
Joshua Epstein, Ronald Walker
Methods in Molecular Medicine
|
June 22, 2005
The SCID-hu myeloma model
Joshua Epstein, Shmuel Yaccoby
The Hematology Journal : the Official Journal of the European Haematology Association
|
September 23, 2003
Consequences of interactions between the bone marrow stroma and myeloma
Joshua Epstein, Shmuel Yaccoby
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research
|
October 21, 2009
Myeloma bone disease
Ralph D Sanderson, Joshua Epstein
Disease Markers
|
November 25, 2006
Biomarkers that discriminate multiple myeloma patients with or without skeletal involvement detected using SELDI-TOF mass spectrometry and statistical and machine learning tools
Sudeepa Bhattacharyya, Joshua Epstein, Larry J Suva
Blood
|
November 8, 2008
Going with the flow, and beyond, in myeloma
Bart Barlogie, Joshua Epstein, John D Shaughnessy
British Journal of Haematology
|
July 26, 2002
Beta(2)-microglobulin as a negative growth regulator of myeloma cells
Rui Min, Zhongkui Li, Joshua Epstein, et al.
British Journal of Haematology
|
March 4, 2006
Fibroblast activation protein (FAP) is upregulated in myelomatous bone and supports myeloma cell survival
Yun Ge, Fenghuang Zhan, Bart Barlogie, et al.
Seminars in Hematology
|
June 26, 2012
Proteasome inhibitors and bone disease
Ya-Wei Qiang, Christoph J Heuck, John D Shaughnessy, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
October 22, 2003
Novel and detrimental effects of lipopolysaccharide on in vitro generation of immature dendritic cells: involvement of mitogen-activated protein kinase p38
Jin Xie, Jianfei Qian, Siqing Wang, et al.
Page
of 9
Search research articles
Search
Showing results (1-10 of 85) with videos related to
Sort By:
Page
of 9
Clinical Advances in Hematology & Oncology : H&O
|
May 27, 2006
Myeloma and bone disease: "the dangerous tango"
Joshua Epstein, Ronald Walker
Methods in Molecular Medicine
|
June 22, 2005
The SCID-hu myeloma model
Joshua Epstein, Shmuel Yaccoby
The Hematology Journal : the Official Journal of the European Haematology Association
|
September 23, 2003
Consequences of interactions between the bone marrow stroma and myeloma
Joshua Epstein, Shmuel Yaccoby
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research
|
October 21, 2009
Myeloma bone disease
Ralph D Sanderson, Joshua Epstein
Disease Markers
|
November 25, 2006
Biomarkers that discriminate multiple myeloma patients with or without skeletal involvement detected using SELDI-TOF mass spectrometry and statistical and machine learning tools
Sudeepa Bhattacharyya, Joshua Epstein, Larry J Suva
Blood
|
November 8, 2008
Going with the flow, and beyond, in myeloma
Bart Barlogie, Joshua Epstein, John D Shaughnessy
British Journal of Haematology
|
July 26, 2002
Beta(2)-microglobulin as a negative growth regulator of myeloma cells
Rui Min, Zhongkui Li, Joshua Epstein, et al.
British Journal of Haematology
|
March 4, 2006
Fibroblast activation protein (FAP) is upregulated in myelomatous bone and supports myeloma cell survival
Yun Ge, Fenghuang Zhan, Bart Barlogie, et al.
Seminars in Hematology
|
June 26, 2012
Proteasome inhibitors and bone disease
Ya-Wei Qiang, Christoph J Heuck, John D Shaughnessy, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
October 22, 2003
Novel and detrimental effects of lipopolysaccharide on in vitro generation of immature dendritic cells: involvement of mitogen-activated protein kinase p38
Jin Xie, Jianfei Qian, Siqing Wang, et al.
Page
of 9